首页> 外国专利> Structure solution of il-13, active sites of il-13, bonding Agents for il-13 and Methods for Design of bonding Agents for IL - 13

Structure solution of il-13, active sites of il-13, bonding Agents for il-13 and Methods for Design of bonding Agents for IL - 13

机译:il-13的结构溶液,il-13的活性位点,il-13的结合剂和IL-13结合剂的设计方法

摘要

We describe a three-dimensional structure in solution of the Human IL - 13. The three-dimensional structure of il-13 may be useful in the design and selection of bonding Agents for il-13. In some embodiments described a Solution containing il-13 and il-13 includes amino acid residues 1 - 113. Il-13 may not be marked or enriched in 15N enriched in 15N, 13C.Il-13 may include four Alpha helices: alfaa, alphabetical, and alfac Alfad, and two beta Chains, beta1 and beta2.The alfaa can include the amino acid residues of the P6 - Q22 il-13 may include the beta1 M33 - W35 of il-13, Alphab can include the amino acid residues of the I52 M43 - il - 13, alfac can include the amino acid residues of the A59 - F70 il-13The beta2 may include amino acid residues k89 E91 of il-13 and Alfad can include the amino acid residues of the r108 V92 - il - 13.In certain embodiments described an active site of IL - 13, where the active site is characterized by a three-dimensional structure that includes the structural coordinates of the amino acid residues I52, q64 R65 and M66, il-13, + / - an average of Quadratic Deviation S of the main Chain Atoms of the conserved amino acids not more than 1,5 Armstrong.It also describes Methods of using the three-dimensional structure of il-13 to design and select agents Union for il-13. Additionally described bonding Agents for il-13.
机译:我们描述了人类IL-13解决方案中的三维结构。il-13的三维结构可能对il-13结合剂的设计和选择有用。在描述的一些实施方案中,包含il-13和il-13的溶液包含氨基酸残基1-113。II-13可以不标记或富集在富含15N,13C的15N中。III-13可以包括四个Alpha螺旋:α,字母和Alfac Alfad,以及两个beta链beta1和beta2。Alfaa可以包含P6-Q22 il-13的氨基酸残基,可以包括il-13的beta1 M33-W35,Alphab可以包含氨基酸残基I52 M43-il-13中的alfac可以包含A59-F70 il-13的氨基酸残基β2可以包括il-13的氨基酸残基k89 E91,而Alfad可以包括r108 V92-il的氨基酸残基-13。在某些实施方案中,描述了IL-13的活性位点,其中该活性位点的特征在于三维结构,该三维结构包括氨基酸残基I52,q64,R65和M66的结构坐标,il-13,+ /-保守氨基酸主链原子的二次方偏差S的平均值不大于1,5阿姆斯特朗(Armstrong)还介绍了使用il-13的三维结构来设计和选择il-13代理的方法。额外描述的il-13粘合剂。

著录项

  • 公开/公告号AR036333A1

    专利类型

  • 公开/公告日2004-09-01

    原文格式PDF

  • 申请/专利权人 WYETH;WYETH CORP;

    申请/专利号AR2002P102167

  • 发明设计人

    申请日2002-06-07

  • 分类号C07K14/54;G06T17/00;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号